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Endovascular management of massive broncho
pulmonary fistula e A series of 28 cases
N.N. Khanna, Suparna Rao, Obiora Ajuluchukwu
Indraprastha Apollo Hospital, New Delhi, India
Background: BronchoePulmonary Fistula (BPF) occurs in 2-3 per
100,000 population. They could be congenital or acquired and are
usually associated with Hereditary HemorrhagicTelengiectasia
(70 %). They could be either single or multiple, central (PA to LA
Fistula) or peripheral (PA to PV Fistula). Usually they are asymp-
tomatic (30 e 55 %) but can present with cyanosis, dyspnea on
exertion, neurological symptoms (migraine, vertigo, TIA, paresis,
numbness, syncope, confusion, cerebral abscess, seizures) or
haemoptysis and haemothorax. Diagnosis is confirmed by
contrast (air bubble) echocardiography or CT / conventional
angiography. Pneumonectomy, lobectomy, local excision and
ligation of the pulmonary artery used to be the available treat-
ments but carried a significantmorbidity andmortality. Currently,
Endovascular Treatment is emerging as a promising alternative
and our series is perhaps the largest one.
Methods: The diagnosis is confirmed by angiography, which is
performed in many views to delineate the point of communica-
tion. Long sheath is introduced and a Berman catheter is then
advanced via the long sheath and the balloon is inflated. The large
flow across the BPF guides the balloon catheter to the branch
supplying the BPF. The Fistula is closed either by coil embolization
(Bioptome assisted) or Amplatzer ASD Device or Vascular Plug (I,
II, III). The saturations (ideally PO2) usually normalizes after
complete occlusion.
Results: N : 28; Age : 26 +/- 3.5 Yrs Central : 3/28; Peripheral : 25/28
Coil Embolisation : 8; Device Closure : 23 (In 3 patients, additional
coils were used) Technical Success : 100%; Repeat Procedure : 5/28
Spo2 Pre Op : 70 +/- 2%; Spo2 Post Op : 95.4 +/- 3%.
Conclusions: Most of the massive BPF can be managed by endo-
vascular techniques and pneumonectomy or other major surgery
can be avoided. This series of 28 successfully treated cases of
Central and Peripheral Bronchopulmonary AV Malformations is
probably one of the largest series.
Endovascular interventions in Takayasu arteritis
N.N. Khanna, Suparna Rao, Obiora Ajuluchukwu
Indraprastha Apollo Hospital, New Delhi, India
Background: Takayasu Arteritis of Supra Aortic Vessels is a wide-
spread panarteritis prevalent in India, South East Asia, Africa and
SouthAmerica. The exact etiology althoughunknown is thought to
be of autoimmune etiology and associated with abnormalities of
humoral and cellular immunity. These lesions are densely fibrotic,
multifocal and have a strong tendency to reoccur at the same or at
different sites. Surgical reconstruction is difficult because of
extensive fibrosis and adhesions of periarterial tissues. Endovas-
cular Interventions are now emerging a treatment of choice.
Methods: 143 consecutive patients of Takayasu Arteritis involving
aorta and Carotid and Subclavian arteries were treated by endo-
vascular interventions e Balloon angioplasty/stents/stent grafts.
Access was gained by femoral artery or brachial artery approach.
Lesionswere initially dilatedwith optimal sized balloons and then
stented if required. The patients were put on dual antiplatelet
therapy (aspirin 75mg and clopidogrel 75mg/day) and immuno-
suppressive therapy in form of prednisolone (1 mg/kg/day). The
disease activity was monitored by erythrocyte sedimentation rate
and levels of C Reactive Proteins. Angiography was done at the
end of one year and 3 years.
Results:
Conclusions: Endovascular interventions have emerged as the
treatment of choice for both stenotic& aneurysmal lesions. It is
easy, safe and efficacious. Multiple lesions and multiple vessels
can be treated at the same time. Stents have improved the results
although Drug Eluting and Cutting balloons have also been suc-
cessfully used.
Percutaneous thromboaspiration and
thrombolysis in massive pulmonary embolism e
A series of 45 consecutive cases
N.N. Khanna, Suparna Rao, Obiora Ajuluchukwu
Indraprastha Apollo Hospital, New Delhi, India
Background: Massive Pulmonary Embolism (PE) is associated with
highmorbidity andmortality due to thrombotic occlusion of main
pulmonary artery and/or both major pulmonary arteries leading
to severe hypoxemia, pulmonary artery hypertension and
cardiogenic shock. Prompt restoration of flow inmajor pulmonary
arteries is themost important aspect of therapy inmassive PE. Till
Number Carotid artery Subclavian artery Aorta
25 74 47
Common Carotid - 19 Thoracic Aorta - 29
Internal Carotid - 06 Abdominal Aorta - 18
STENOSIS 21 71 31
ANEURYSM 01 03 16
STENTS 11 24 18
Technical success 22/25 (88 %) 88 % 47/ 47 (100 %)
Follow up at 3 yrs restenosis in 9 pts
(treated by PTBA / stent)
12.5% (treated by
PTBA / stent)
Restenosis in 7 %
Aneurysm in 2 , New Lesions in 4 ,
Disease Reactivity in 5
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now, open surgical pulmonary endarterectomy was the only op-
tion but carried a high mortality in hemodynamically unstable
patients. Catheter based pulmonary thromboaspiration and
intrapulmonary thrombolysis can be used. We present our expe-
rience in 45 consecutive patients of massive PE presenting with
cardiogenic shock.
Methods: Diagnosis was confirmed by CT Pulmonary Angiog-
raphy. Venous access was taken from Rt. Common Femoral vein
and a 10F sheath was introduced. 10F multipurpose guiding
catheter was used to sequentially aspirate clot from main and
segmental pulmonary arteries. Residual clot was macerated with
0.035” guidewire and two multi side hole catheters were placed in
each pulmonary artery. Tissue Plasminogen Activator (rtPA) was
given at a dose of 2mg/hr (in cases where thrombolysis or anti-
coagulation was not contraindicated). Clinical and angiographic
success was monitored by increase in oxygen saturation (Sp02),
improvement in hemodynamics, and angiographic assessment
(>50 % reduction in clot burden). Follow-up CT scan was per-
formed in 28 patients.
Results: N e 45; Only Thromboaspiration (contraindication to
thrombolysis) in 8; Thromboaspiration + CDTT in 37 patients.
>50% Drop in PAP 44/45; Significant improvement in SpO2 43/45
and > 50% reduction in clot burden 44/45.
Post Procedural SBP > 100 mmHg - 41/45, Mean Procedure Time
was 27.8min and mean fall in Hb was 2gm%. Death in 1/45. Post
procedure CT Pulmonary Angiography- Complete lysis seen in all
survivors
Conclusion: Percutaneous catheter directed thrombolysis and
thrombectomy is a useful, lifesaving procedure for treatment of
massive PE with cardiogenic shock.
Trans-radial procedures in octagenarians with
suspected coronary artery disease
V.S.R. Bhupal, M. Jyotsna, D. Seshagiri Rao
Nizam's Institue of Medical Sciences, Hyderabad, India
Background: Trans-radial procedures are gaining importance due
to less access site bleeding and patient comfort due to early
mobilization.In the hands of experienced operators and high-
volume transradial catheterization centers, transradial coronary
angiography and intervention offer improved patient comfort,
decreased access-site complications, and decreased costs without
compromising procedural success or long-term outcomes. Pa-
tients presenting with ST-elevation myocardial infarction
(STEMI), in particular, benefit from a transradial approach to
coronary intervention.
We wanted to study the feasibility and safety of transradial
procedures in octagenarians.
Methods: We present observational data of trans-radial pro-
cedures done in octagenarians in whom CAD was suspected over
a period of 2years from 2012JAN to 2013 DEC at a single tertiary
care center by a single experienced operator. Trans-radial angio or
angioplasty was done using 6FCcordis trans-radial kit through
right or left radial route. Data of risk factors, type of presentation
of CAD, LV function, blood chemistry, procedural details of
angio(tortuosity of vessels including radial loops or calcification of
vessels, difficulty in negotiation into ascending aorta, procedural
time, fluoroscopic time, amount of contrast, need to shift to
femoral, local vascular site complications) and PCI (in addition
effective support of guide catheter, complications of PCI)
werecollected. Outcomes assessed were procedure failure rate
and complication ratepost-procedurally in the hospital and after
discharge 15 days.
Results: Total of199 patients were included for final data analysis.
Average patient age was 82.3 ± 1.7 years, with average height of
156.8 ± 8.4 cm and average weight of 60.1 ± 11.4 kg. Out of them 60
were females and 139 were males. One forty five patients (72.9%)
underwent angiogram and PCI in 54 patients (27.1%). HTN was
present in 132 (66.3%) and DM in 84(42.9%) patients.Presentation
was ACS in 80 (40.2%) patients. LV dysfunction was present in 75
(37.7%) patients. Right radial route was used in 190 patients and
left radial route in 9 patients. Average procedural time for CAG
was 9.3 ± 3.8 minutes and 17.5 ± 5.9 minutes for PCI. Mean
contrast volume for CAG was 57.4 ± 22.3 ml andfor PCI was 89.3 ±
28.9 ml. Subclavian vessel tortuosity was present in 9 (4.5%) and
one case of arterialusoria. 68 lesions were treated in 54 PCI group.
Significant lesional calcium was present in 36 (52.91%) lesions. GP
2b/3a inhibitors were used in 14 (24.9%) patients of PCI group.
Three cases of PCI procedure failure accounted for a failure rate of
1.5%.No radial to femoral shifts (means 0% radial procedural
failure) and no hematomas. Radial spasm in 3 patients relieved
with NTG. Asymptomatic radial pulse loss was in 3 (1.5%) patients
on the next day of procedure and at 15 days only in one (0.5%)
patient. So, in hospital complication rate related to radial proce-
dure was 6 (3%), which decreased to 0.5% at 15 day. No specified
complications were noted in any of the patients.
Conclusion: Radial artery procedures are feasible and safe even in
octagenarianswith good procedural success without significant
complication rate.
Efficacy and safety of heparin, heparin+GPI,
bivalirudin during PCI e A prospective real world
study
A. Dua, A. Sethi, A. Seth, T.S. Kler, S. Bhandari, S. Chandra,
A. Mathur, P. Agarwal, V. Jetly, V. Rastogi, V. Kumar, U. Kaul
Fortis Escorts Heart Institute, New Delhi, India
Background: UFH has always been the antithrombotic of choice
during PCI. Nevertheless it is associatedwithmajor adverse effects
like bleeding. Bivalirudin has been in use off late and has been
found to be favorable in terms of efficacy& safety. This prospective
observational study was an endeavor to find out its clinical utility
and cost effectiveness in our setting, in a real world scenario.
Aim & Objective: To compare the anti-thrombotic strategy using
Bivalirudin vs. heparin + GPI and UHF alone for patients under-
going PCI at FEHI, a tertiary care centre.
Methods: The study includes 1453 all comer patients, who un-
derwent PCI during April 2012 to Sept 2012. Apart from de-
mographic variables, patients were also characterized according
to clinical presentation. Study patients were divided into three
groups i.e. UHF alone, UFH + GPI and Bivalirudin. Patients were
followed up at a thirty day period post procedure. Data was
analyzed using SPSS & standard tests of statistical significance.
Results: Study population although comparable to other large
registries, included younger patients as well as more number of
diabetics as expected. Majority of the patients underwent PCI due
to presentation as ACS. Use of UFH was significantly less in STEMI
patients as compared to other agents. Major bleeding was least i.e.
1.59% in Bivalirudin group as compared to 3.49% with GPI & 5.97%
with UFH alone (p¼0.007). Use of Bivalirudin resulted in >50% RR
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